Results 111 to 120 of about 4,550 (156)

In vitro evidence of HER2-selective cytotoxicity by scFv(Herceptin)-PE-STXA immunotoxin in gastric cancer cells. [PDF]

Biochem Biophys Rep
Sedighian H, Abdi A, Goleij Z, Fasihi-Ramandi M, Fooladi AAI.   +4 more
europepmc   +1 more source

Stereotactic lesioning of cholinergic cells by injection of ME20.4 Saporin in the nucleus basalis of Meynert in a rhesus monkey (Macaca mulatta). [PDF]

J Neuropathol Exp Neurol
Nazmuddin M, Stammes MA, Klink PC, Vernes MK, Bakker J, Langermans JAM, van Laar T, Philippens IHCHM.   +7 more
europepmc   +1 more source

Cadherin 17 Nanobody-Mediated Near-Infrared-II Fluorescence Imaging-Guided Surgery and Immunotoxin Delivery for Colorectal Cancer. [PDF]

Biomater Res
Ding Y, Zhou R, Shi G, Jiang Y, Li Z, Xu X, Ma J, Huang J, Fu C, Zhou H, Wang H, Li J, Dong Z, Yu Q, Jiang K, An Y, Liu Y, Li Y, Yu L, Li Z, Zhang X, Wang J.   +21 more
europepmc   +1 more source

Next generation targeted non-genotoxic conditioning for hematopoietic stem cell and hematopoietic stem cell-based gene therapy. [PDF]

Front Immunol
Okalova J, Spencer TH, Chandrakasan S.
europepmc   +1 more source

Next generation of "magic bullets", solutions from the microbial pangenome. [PDF]

EMBO Mol Med
Masignani V, Rappuoli R, Pizza M.
europepmc   +1 more source

Conjugation of anti-HIV gp41 monoclonal antibody to a drug capable of targeting resting lymphocytes produces an effective cytotoxic anti-HIV immunoconjugate. [PDF]

J Virol
Pincus SH, Cole FM, Ober K, Tokmina-Lukaszewska M, Marcotte T, Kovacs EW, Zhu T, Khasanov A, Copié V, Peters T.   +9 more
europepmc   +1 more source

A novel shark VNAR antibody-based immunotoxin targeting TROP-2 for cancer therapy. [PDF]

Acta Pharm Sin B
Xi X, Wang Y, An G, Feng S, Zhu Q, Wu Z, Chen J, Zuo Z, Wang Q, Wang MW, Gu Y.   +10 more
europepmc   +1 more source

Engineered probiotic-mediated intratumoral delivery and controlled release of bacterial collagenase for cancer therapy. [PDF]

Synth Syst Biotechnol
Li HR, Ye BC.
europepmc   +1 more source

CD22 Immunotoxin [PDF]

, 2020
openaire   +1 more source

The immunotoxin targeting PRLR increases tamoxifen sensitivity and enhances the efficacy of chemotherapy in breast cancer. [PDF]

J Exp Clin Cancer Res
Zhang J, Liu J, Yue Y, Wang L, He Q, Xu S, Li J, Liao Y, Chen Y, Wang S, Xie Y, Zhang B, Bian Y, Dimitrov DS, Yuan Y, Zhu J.   +15 more
europepmc   +1 more source